[Physiologically active substances derived from activated platelets: overview in clinical medicine].
Yatomi
Yutaka
Y
D000818:Animals; D001792:Blood Platelets / Q000378:metabolism*; D006801:Humans; D008246:Lysophospholipids / Q000378:metabolism; D015539:Platelet Activation / Q000502:physiology*; D017713:Platelet Transfusion; D013110:Sphingosine / Q000031:analogs & derivatives / Q000378:metabolism; D013928:Thromboxane A2 / Q000378:metabolism; D042461:Vascular Endothelial Growth Factor A / Q000502:physiology
D008246:Lysophospholipids; D042461:Vascular Endothelial Growth Factor A; C060506:sphingosine 1-phosphate; D013928:Thromboxane A2; D013110:Sphingosine